Wealth Awesome
TSX open
Loading markets…
Interactive Brokers: options trading made simple with the IBKR Options Wizard.
Stocks/TSX/FRX

Fennec Pharmaceuticals Inc (FRX : TSX)

$18.35CAD+1.79 (10.81%)Close of 2026-11-16

Common Stock

Follow FRX

FRX

Fennec Pharmaceuticals Inc

Source:WealthAwesomeWealthAwesome
↑ $3.95 (27.43%)
30 day period
$13.29$15.82$18.35Oct 5Oct 27Nov 16

Performance

1 Day

+10.81%

1 Week

+38.07%

1 Month

+27.61%

YTD

+76.27%

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Key Statistics

Market Cap

$466.04M

52W High

$17.64

52W Low

$7.59

P/E Ratio

-

50 Day MA

$15.12

200 Day MA

$12.91

Beta

1.21

Dividend Yield

-

WA Score

How FRX stacks up against 944 Canadian stocks

out of 99

  • Value47

    Not profitable over the last 12 months.

  • Quality
  • Momentum91

    76.3% this year, above its 200-day average, 100% of the way up its 52-week range.

  • Analysts
  • Insiders

Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks

Performance history

FRX returns since 2023

Fennec Pharmaceuticals Inc has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −62.8% (Mar 2024 to Nov 2024).

1 year / yr

+47.4%

3 years / yr

+18.5%

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2023*+41.4%
  • 2024−41.5%
  • 2025+19.5%
  • 2026*+73.1%

* Partial year (first year of data, or year to date).

$10,000 invested in FRX

  • 1 year ago$14,739
  • 2023 (start of our data)$17,118
Best year
2025: +19.5%
Worst year
2024: −41.5%
All-time high in our data
$18 on Nov 16, 2026 · at the high

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.

Earnings

FRX earnings history

Fennec Pharmaceuticals Inc beat the EPS estimate in 3 of its last 4 reported quarters.

-0.1853-0.00720.1709 24-1225-0325-0625-0925-1226-0326-0626-09 Estimate Actual (≥0) Actual (<0) Wealth Awesome
Quarter endingReportedEPSEstimateSurprise
Sep 30, 2026Nov 12, 2026$0.17$0.15+15.8%
Jun 30, 2026Aug 11, 2026$0.07$0.03+133.3%
Mar 31, 2026May 14, 2026$0.01−$0.02+168.5%
Dec 31, 2025Mar 24, 2026−$0.14$0.05−380.0%
Sep 30, 2025Nov 13, 2025−$0.03−$0.04+25.0%
Jun 30, 2025Aug 14, 2025−$0.15−$0.04−275.0%
Mar 31, 2025May 13, 2025−$0.06−$0.12+50.0%
Dec 31, 2024Mar 10, 2025−$0.09−$0.19+53.4%

EPS as reported vs consensus estimate. TSX earnings calendar →

Awesome Portfolio™

Looking past FRX? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/16/2026$16.24$18.35$16.24$18.35$18.35591
11/13/2026$15.65$16.79$15.65$16.56$16.562,060
11/12/2026$15.65$16.50$15.65$16.05$16.052,430
11/11/2026$13.29$13.29$13.29$13.29$13.290
11/10/2026$13.29$13.29$13.29$13.29$13.290
11/9/2026$13.29$13.29$13.29$13.29$13.290
11/6/2026$13.29$13.29$13.29$13.29$13.290
11/5/2026$13.29$13.29$13.29$13.29$13.29300
11/4/2026$14.46$14.46$14.46$14.46$14.46200
11/3/2026$14.88$14.99$14.88$14.99$14.99350

Analyst Price Targets

Based on analyst covering FRX · as of Sep 17, 2026

📈

Wall Street analysts forecast FRX stock price to rise 409.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$93.57

+409.9% Upside

Current Price

C$18.35

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on FRX's historical volatility

HistoricalForecast68%95%
C$7.85C$17.04C$26.22C$35.41C$44.59C$53.78TodayJun 29Sep 11Nov 16Dec 29Feb 11Mar 26

30-Day Vol

78.0%

Annualized

90-Day Vol

68.0%

Annualized

Trend (90d)

+31.8%

Annualized drift

90d Mean

C$20.56

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$19.06C$14.56 – C$24.94
60 trading daysC$19.80C$13.53 – C$28.96
90 trading daysC$20.56C$12.90 – C$32.76

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Financials

Revenue (TTM)
$59.22M
EBITDA
$-1.02M
Profit Margin
-5.49%
ROE (TTM)
-18.58%
EPS (Diluted)
-0.17
Book Value
1.70

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

Free newsletter

The Tuesday Stock Pick

Tuesday morning

One Canadian stock and the case for it

  • The name with the biggest gap to analyst targets
  • The chart, insider buying and what is driving it
  • A plain-English bottom line, no hype

Free. One email a week. Unsubscribe any time.

Common Questions About FRX

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
HWOHigh Arctic Energy Services Inc.$1.74+29.85%
AAVAdvantage Oil & Gas Ltd.$13.45+23.74%
LUCLucara Diamond Corp$0.13+13.64%
TTelus Corp$13.70+12.85%
KELKelt Exploration Ltd.$12.72+10.70%
NVONovo Resources Corp$0.07+8.33%
ELOEloro Resources Ltd.$1.23+7.89%
INO-UNInovalis Real Estate Investment Trust$0.56+7.69%

Free with a Wealth Awesome account

Keep analysing FRX, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.